Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older and have been seen in an outpatient clinic or are currently admitted to the liver and digestive department at one of the University Hospitals in Guadeloupe, French Guiana, or Réunion Island.
- You have been diagnosed with a liver condition called MASLD, which means you have excess fat in your liver along with at least one of the following: being overweight or obese, having type 2 diabetes, or having metabolic syndrome (a combination of conditions such as high blood pressure, high blood sugar, and high cholesterol).
- You are covered by a social security or health insurance scheme.
- You are able and willing to give your free, informed, written agreement to take part before any study procedures begin.
Who may not be able to join:
- You are under 18 years of age.
- You are unable to give your own informed consent, or you are under legal guardianship or judicial protection.
- You have another known cause of chronic liver disease, such as hepatitis B, C, or E, certain autoimmune or inflammatory liver conditions, inherited conditions affecting iron or copper storage, a genetic condition affecting a liver protein called alpha-1 antitrypsin, or liver disease caused by alcohol (confirm with trial site).
- You drink more than 30 grams of alcohol per day if you are a man, or more than 20 grams per day if you are a woman (roughly 2–3 standard drinks per day — confirm with trial site).
- You are currently pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Moana Gelu-Simeon, MD PhD, CHU de la Guadeloupe
Phone: +590590934667
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Allele frequencies of PNPLA3 variants
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.